ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preventive Vaccines Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38Y2682
Home | Market Reports | Health| Pharmacy
Global Preventive Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global Preventive Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-38Y2682
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Astrazeneca plc
CSL Limited
Abbott
GlaxoSmithKline PLC
Serum Institute of India

Preventive Vaccines Market Size

The global Preventive Vaccines market is projected to grow from US$ 59830 million in 2024 to US$ 98050 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period.

Preventive Vaccines Market

Preventive Vaccines Market

Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
The US & Canada market for Preventive Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Preventive Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Preventive Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline and Serum Institute of India, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Preventive Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Preventive Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Preventive Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Preventive Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Preventive Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Preventive Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Preventive Vaccines Market Report

Report Metric Details
Report Name Preventive Vaccines Market
Accounted market size in 2024 US$ 59830 million
Forecasted market size in 2030 US$ 98050 million
CAGR 8.6
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Ltd, Abbott, GlaxoSmithKline, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Preventive Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preventive Vaccines sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Preventive Vaccines Market growing?

Ans: The Preventive Vaccines Market witnessing a CAGR of 8.6 during the forecast period 2025-2030.

What is the Preventive Vaccines Market size in 2030?

Ans: The Preventive Vaccines Market size in 2030 will be US$ 98050 million.

Who are the main players in the Preventive Vaccines Market report?

Ans: The main players in the Preventive Vaccines Market are CSL Ltd, Abbott, GlaxoSmithKline, Serum Institute of India

What are the Application segmentation covered in the Preventive Vaccines Market report?

Ans: The Applications covered in the Preventive Vaccines Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Preventive Vaccines Market report?

Ans: The Types covered in the Preventive Vaccines Market report are Intramuscular Injection, Nasal Spray, Intradermal Shot

Recommended Reports

Human Vaccines

Vaccine Delivery

Animal & Special Vaccines

1 Study Coverage
1.1 Preventive Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Preventive Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market by Application
1.3.1 Global Preventive Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Preventive Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global Preventive Vaccines Revenue by Region
2.2.1 Global Preventive Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Preventive Vaccines Revenue by Region (2019-2024)
2.2.3 Global Preventive Vaccines Revenue by Region (2025-2030)
2.2.4 Global Preventive Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Preventive Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Preventive Vaccines Sales by Region
2.4.1 Global Preventive Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Preventive Vaccines Sales by Region (2019-2024)
2.4.3 Global Preventive Vaccines Sales by Region (2025-2030)
2.4.4 Global Preventive Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Preventive Vaccines Sales by Manufacturers
3.1.1 Global Preventive Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Preventive Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Preventive Vaccines in 2023
3.2 Global Preventive Vaccines Revenue by Manufacturers
3.2.1 Global Preventive Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Preventive Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Preventive Vaccines Revenue in 2023
3.3 Global Key Players of Preventive Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Preventive Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Preventive Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Preventive Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Preventive Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Preventive Vaccines Sales by Type
4.1.1 Global Preventive Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Preventive Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Preventive Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Preventive Vaccines Revenue by Type
4.2.1 Global Preventive Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Preventive Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Preventive Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Preventive Vaccines Price by Type
4.3.1 Global Preventive Vaccines Price by Type (2019-2024)
4.3.2 Global Preventive Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Preventive Vaccines Sales by Application
5.1.1 Global Preventive Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Preventive Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Preventive Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Preventive Vaccines Revenue by Application
5.2.1 Global Preventive Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Preventive Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Preventive Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Preventive Vaccines Price by Application
5.3.1 Global Preventive Vaccines Price by Application (2019-2024)
5.3.2 Global Preventive Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Preventive Vaccines Market Size by Type
6.1.1 US & Canada Preventive Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Preventive Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Preventive Vaccines Market Size by Application
6.2.1 US & Canada Preventive Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Preventive Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Preventive Vaccines Market Size by Country
6.3.1 US & Canada Preventive Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Preventive Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada Preventive Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Preventive Vaccines Market Size by Type
7.1.1 Europe Preventive Vaccines Sales by Type (2019-2030)
7.1.2 Europe Preventive Vaccines Revenue by Type (2019-2030)
7.2 Europe Preventive Vaccines Market Size by Application
7.2.1 Europe Preventive Vaccines Sales by Application (2019-2030)
7.2.2 Europe Preventive Vaccines Revenue by Application (2019-2030)
7.3 Europe Preventive Vaccines Market Size by Country
7.3.1 Europe Preventive Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Preventive Vaccines Sales by Country (2019-2030)
7.3.3 Europe Preventive Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Preventive Vaccines Market Size
8.1.1 China Preventive Vaccines Sales (2019-2030)
8.1.2 China Preventive Vaccines Revenue (2019-2030)
8.2 China Preventive Vaccines Market Size by Application
8.2.1 China Preventive Vaccines Sales by Application (2019-2030)
8.2.2 China Preventive Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Preventive Vaccines Market Size by Type
9.1.1 Asia Preventive Vaccines Sales by Type (2019-2030)
9.1.2 Asia Preventive Vaccines Revenue by Type (2019-2030)
9.2 Asia Preventive Vaccines Market Size by Application
9.2.1 Asia Preventive Vaccines Sales by Application (2019-2030)
9.2.2 Asia Preventive Vaccines Revenue by Application (2019-2030)
9.3 Asia Preventive Vaccines Sales by Region
9.3.1 Asia Preventive Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Preventive Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Preventive Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Preventive Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Preventive Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Preventive Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Preventive Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Preventive Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Preventive Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Preventive Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Preventive Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Preventive Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Preventive Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Sanofi Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 AstraZeneca Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 CSL Ltd
11.3.1 CSL Ltd Company Information
11.3.2 CSL Ltd Overview
11.3.3 CSL Ltd Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CSL Ltd Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Ltd Recent Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Overview
11.4.3 Abbott Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Abbott Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GlaxoSmithKline Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Serum Institute of India
11.6.1 Serum Institute of India Company Information
11.6.2 Serum Institute of India Overview
11.6.3 Serum Institute of India Preventive Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Serum Institute of India Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Serum Institute of India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Preventive Vaccines Industry Chain Analysis
12.2 Preventive Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Preventive Vaccines Production Mode & Process
12.4 Preventive Vaccines Sales and Marketing
12.4.1 Preventive Vaccines Sales Channels
12.4.2 Preventive Vaccines Distributors
12.5 Preventive Vaccines Customers
13 Market Dynamics
13.1 Preventive Vaccines Industry Trends
13.2 Preventive Vaccines Market Drivers
13.3 Preventive Vaccines Market Challenges
13.4 Preventive Vaccines Market Restraints
14 Key Findings in The Global Preventive Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Sanofi
Astrazeneca plc
CSL Limited
Abbott
GlaxoSmithKline PLC
Serum Institute of India
List of Tables
    Table 1. Global Preventive Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Intramuscular Injection
    Table 3. Major Manufacturers of Nasal Spray
    Table 4. Major Manufacturers of Intradermal Shot
    Table 5. Global Preventive Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Preventive Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Preventive Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Preventive Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Preventive Vaccines Revenue Market Share by Region (2019-2024)
    Table 10. Global Preventive Vaccines Revenue Market Share by Region (2025-2030)
    Table 11. Global Preventive Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Preventive Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 13. Global Preventive Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 14. Global Preventive Vaccines Sales Market Share by Region (2019-2024)
    Table 15. Global Preventive Vaccines Sales Market Share by Region (2025-2030)
    Table 16. Global Preventive Vaccines Sales by Manufacturers (2019-2024) & (K Doses)
    Table 17. Global Preventive Vaccines Sales Share by Manufacturers (2019-2024)
    Table 18. Global Preventive Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Preventive Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Preventive Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Preventive Vaccines Price by Manufacturers 2019-2024 (USD/Doses)
    Table 22. Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Preventive Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Vaccines as of 2023)
    Table 24. Global Key Manufacturers of Preventive Vaccines, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Preventive Vaccines, Product Offered and Application
    Table 26. Global Key Manufacturers of Preventive Vaccines, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 29. Global Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 30. Global Preventive Vaccines Sales Share by Type (2019-2024)
    Table 31. Global Preventive Vaccines Sales Share by Type (2025-2030)
    Table 32. Global Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Preventive Vaccines Revenue Share by Type (2019-2024)
    Table 35. Global Preventive Vaccines Revenue Share by Type (2025-2030)
    Table 36. Preventive Vaccines Price by Type (2019-2024) & (USD/Doses)
    Table 37. Global Preventive Vaccines Price Forecast by Type (2025-2030) & (USD/Doses)
    Table 38. Global Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 39. Global Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 40. Global Preventive Vaccines Sales Share by Application (2019-2024)
    Table 41. Global Preventive Vaccines Sales Share by Application (2025-2030)
    Table 42. Global Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Preventive Vaccines Revenue Share by Application (2019-2024)
    Table 45. Global Preventive Vaccines Revenue Share by Application (2025-2030)
    Table 46. Preventive Vaccines Price by Application (2019-2024) & (USD/Doses)
    Table 47. Global Preventive Vaccines Price Forecast by Application (2025-2030) & (USD/Doses)
    Table 48. US & Canada Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 49. US & Canada Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 50. US & Canada Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 53. US & Canada Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 54. US & Canada Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Preventive Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Preventive Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Preventive Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 60. US & Canada Preventive Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 61. Europe Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 62. Europe Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 63. Europe Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 66. Europe Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 67. Europe Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Preventive Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Preventive Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Preventive Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 73. Europe Preventive Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 74. China Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 75. China Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 76. China Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 79. China Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 80. China Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 83. Asia Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 84. Asia Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 87. Asia Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 88. Asia Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Preventive Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Preventive Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Preventive Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Preventive Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 94. Asia Preventive Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 95. Middle East, Africa and Latin America Preventive Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 96. Middle East, Africa and Latin America Preventive Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 97. Middle East, Africa and Latin America Preventive Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Preventive Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Preventive Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America Preventive Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America Preventive Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Preventive Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Preventive Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Preventive Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Preventive Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Preventive Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 107. Middle East, Africa and Latin America Preventive Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 108. Sanofi Company Information
    Table 109. Sanofi Description and Major Businesses
    Table 110. Sanofi Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 111. Sanofi Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Sanofi Recent Developments
    Table 113. AstraZeneca Company Information
    Table 114. AstraZeneca Description and Major Businesses
    Table 115. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 116. AstraZeneca Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. AstraZeneca Recent Developments
    Table 118. CSL Ltd Company Information
    Table 119. CSL Ltd Description and Major Businesses
    Table 120. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 121. CSL Ltd Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. CSL Ltd Recent Developments
    Table 123. Abbott Company Information
    Table 124. Abbott Description and Major Businesses
    Table 125. Abbott Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 126. Abbott Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Abbott Recent Developments
    Table 128. GlaxoSmithKline Company Information
    Table 129. GlaxoSmithKline Description and Major Businesses
    Table 130. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 131. GlaxoSmithKline Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. GlaxoSmithKline Recent Developments
    Table 133. Serum Institute of India Company Information
    Table 134. Serum Institute of India Description and Major Businesses
    Table 135. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 136. Serum Institute of India Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Serum Institute of India Recent Developments
    Table 138. Key Raw Materials Lists
    Table 139. Raw Materials Key Suppliers Lists
    Table 140. Preventive Vaccines Distributors List
    Table 141. Preventive Vaccines Customers List
    Table 142. Preventive Vaccines Market Trends
    Table 143. Preventive Vaccines Market Drivers
    Table 144. Preventive Vaccines Market Challenges
    Table 145. Preventive Vaccines Market Restraints
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Preventive Vaccines Product Picture
    Figure 2. Global Preventive Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Preventive Vaccines Market Share by Type in 2023 & 2030
    Figure 4. Intramuscular Injection Product Picture
    Figure 5. Nasal Spray Product Picture
    Figure 6. Intradermal Shot Product Picture
    Figure 7. Global Preventive Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Preventive Vaccines Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Other
    Figure 12. Preventive Vaccines Report Years Considered
    Figure 13. Global Preventive Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Preventive Vaccines Revenue 2019-2030 (US$ Million)
    Figure 15. Global Preventive Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Preventive Vaccines Revenue Market Share by Region (2019-2030)
    Figure 17. Global Preventive Vaccines Sales 2019-2030 ((K Doses)
    Figure 18. Global Preventive Vaccines Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Preventive Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 20. US & Canada Preventive Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Preventive Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 22. Europe Preventive Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Preventive Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 24. China Preventive Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Preventive Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 26. Asia (excluding China) Preventive Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Preventive Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 28. Middle East, Africa and Latin America Preventive Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Preventive Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Preventive Vaccines in the World: Market Share by Preventive Vaccines Revenue in 2023
    Figure 31. Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 33. Global Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 34. Global Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 35. Global Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Preventive Vaccines Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Preventive Vaccines Sales Share by Country (2019-2030)
    Figure 42. U.S. Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 45. Europe Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 47. Europe Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Preventive Vaccines Revenue Share by Country (2019-2030)
    Figure 49. Europe Preventive Vaccines Sales Share by Country (2019-2030)
    Figure 50. Germany Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 51. France Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. China Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 56. China Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 57. China Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 58. China Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 60. Asia Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 62. Asia Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Preventive Vaccines Revenue Share by Region (2019-2030)
    Figure 64. Asia Preventive Vaccines Sales Share by Region (2019-2030)
    Figure 65. Japan Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. India Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Preventive Vaccines Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Preventive Vaccines Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Preventive Vaccines Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Preventive Vaccines Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Preventive Vaccines Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Preventive Vaccines Sales Share by Country (2019-2030)
    Figure 76. Brazil Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Preventive Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. Preventive Vaccines Value Chain
    Figure 82. Preventive Vaccines Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Prophylactic Human Vaccine Market Research Report 2025
Global Pediatric Preventable Vaccine Market Research Report 2024
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Preventive Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Preventable Vaccines Market Research Report 2024
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Global Antibacterial Vaccines Market Research Report 2024
Global Infection Prevention Products Market Insights Forecast to 2030
Infection Prevention Market
Global Vaccines For Children Market Insights Forecast to 2030
Global Human Vaccination Market Research Report 2025
Global Travelers Vaccination Market Research Report 2025
Global Hospital Infection Prevention And Control Market Insights Forecast to 2030
Global Cattle Vaccines Market Insights Forecast to 2030
Global Veterinary Vaccination Market Research Report 2025
Global Travelers Vaccines Market Research Report 2025
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Yellow Fever Vaccines Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions